Marker Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $861 | $349 | $2,252 | $1,926 |
Gross Profit | 349 | -2,835 | -1,545 | |
EBITDA | -4,261 | -4,446 | 2,730 | -2,400 |
EBIT | -8,602 | 2,729 | ||
Net Income | -4,015 | -4,446 | -3,838 | -2,308 |
Net Change In Cash | 861 | 349 | 2,252 | 1,926 |
Free Cash Flow | -1,878 | -5,499 | -4,703 | 1,197 |
Cash | 10,461 | 13,693 | 19,192 | 8,999 |
Basic Shares | 13,956 | 11,106 | 9,101 | 8,923 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,591 | $3,311 | $9,005 | $1,242 |
Gross Profit | -6,877 | -7,106 | 5,324 | -1,921 |
EBITDA | -4,527 | -11,270 | -19,791 | -36,315 |
EBIT | -4,527 | -14,059 | -23,471 | -39,478 |
Net Income | -10,731 | -8,237 | -29,931 | -41,879 |
Net Change In Cash | 6,591 | 3,311 | 9,005 | 1,242 |
Free Cash Flow | -10,910 | -16,439 | -31,917 | -30,410 |
Cash | 19,192 | 15,111 | 11,782 | 42,351 |
Basic Shares | 8,980 | 8,809 | 8,351 | 7,651 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.29 |
2025-03-31 | -$0.42 |
2024-12-31 | -$0.42 |
2024-09-30 | -$0.26 |
